Home » Topics » Regulatory » Patents

Patents
RSS

Merck KGaA describes PDE IV inhibitors

April 24, 1997

Azko Nobel discloses antiglucocorticoids

April 24, 1997

Antioxidants/hypolipidemics from ADIR

April 24, 1997

Ono discloses ICE inhibitors

April 23, 1997

Novel 5-HT uptake inhibitors from Bristol-Myers Squibb

April 23, 1997

New agents for postmenopausal syndrome described by Lilly

April 23, 1997

Bayer discloses antiretroviral agents

April 23, 1997

Princeton and Lilly disclose nonclassical antifolates

April 22, 1997

Roche reveals cephalosporins

April 22, 1997

ACAT inhibitors from Nihon Nohyaku

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...